A Canadian cannabis producer has adjusted its construction plans for a facility expansion in British Columbia, Canada, in an attempt to prevent disruption to its cash flow.

In an update to investors issued on Monday (October 21), Zenabis Global (TSX:ZENA) confirmed the adjusted timeline for the facility. The new plan will delay the site in reaching full capacity.

According to Andrew Grieve, CEO of Zenabis, the facility will still achieve production of 96,400 kilograms by the end of 2019.

Zenabis will split its remaining Zenabis Langley expansion into two phases: Zenabis Langley — Part 2B and Zenabis Langley — Part 2C.

“While the timeline revision for Zenabis Langley will delay achieving full design capacity at the facility, we expect to have 96,400 kg of capacity licensed and operational by the end of 2019 with approval of the Zenabis Langley – Part 2A amendment,” Grieve said.

Zenabis filed an amendment for the 2A phase of its expansion in September and anticipates it will obtain Health Canada approval this year.

The firm plans to submit its license amendment to the regulator for the 2B section in November, while 2C will have to wait until early 2020.

Zenabis indicated that this decision was made due to market conditions at the moment and as way to lower ramp-up risk.

The marijuana producer has lofty expectations for its facility operations and production in Langley.

“By early in the first quarter of 2020, we expect to have 111,200 kilograms of capacity licensed and operational with the approval of the Zenabis Langley — Part 2B amendment,” Grieve said.

The market did not take kindly to the delay in Monday’s trading session. Shares of Zenabis opened at C$0.68 and then quickly fell by 4.41 percent to C$0.65 as of 10:35 a.m. EDT following the announcement.

On analyst data aggregator TipRanks, Zenabis currently holds a “moderate buy” rating based on two recent reviews of the stock.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less